Clinical trials
Withdrawn Phase 3 COVID-19 trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
58 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 28 |
| 2021 | 16 |
| 2022 | 5 |
| 2023 | 6 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 58 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Larkin Community Hospital | 4 |
| Abderrahmane Mami Hospital | 2 |
| Applied Biology, Inc. | 2 |
| CanSino Biologics Inc. | 2 |
| Clover Biopharmaceuticals AUS Pty | 2 |
| Mario Negri Institute for Pharmacological Research | 2 |
| Murdoch Childrens Research Institute | 2 |
| Romark Laboratories L.C. | 2 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| AstraZeneca | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 58 |
| Coronavirus Infections | 4 |
| Severe Acute Respiratory Syndrome | 3 |
| Diabetes Mellitus | 2 |
| Respiratory Distress Syndrome | 2 |
| Community-Acquired Pneumonia | 1 |
| Coronary Artery Disease | 1 |
| Dyspnea | 1 |
| Hemostatic Disorders | 1 |
| Kidney Failure, Chronic | 1 |
Trials
Showing 1 to 25 of 58. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.